Approval · Notice of Compliance 11072 · 2010
ZOPICLONE: Notice of Compliance 11072
Issued February 19, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11072
- Date
- February 19, 2010
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Hypnotic and sedative
- Canadian reference product
- IMOVANE (Aventis Pharma Inc.)